clinical trial · NCT05827978
Study of mRNA-1010 Seasonal Influenza Vaccine in Adults
ModernaTX, Inc.·phase3·completed·n = 8,411
Seasonal InfluenzamRNA-1010Licensed Quadrivalent Inactivated Seasonal Influenza Vaccine
brief summary
This study includes 3 parts: Parts A, B, and C. The purpose of this study is to evaluate the immunogenicity and safety of mRNA-1010 seasonal influenza vaccine in adults.
started
Apr 17, 2023
primary completion
Jun 24, 2024
completion
Jun 24, 2024
last updated
Jul 10, 2025
official title
A Phase 3, Randomized, Stratified, Observer-Blind, Active-Controlled Study to Evaluate the Immunogenicity, Reactogenicity and Safety of mRNA-1010 Seasonal Influenza Vaccine in Adults 18 Years and Older
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol